Document is current
Any future updates will be listed below
-
Authors
Krishnamurthy, Sruthi Sankari
Buzatto, Adriana Zardini
Campkin, Caley
Müller, Hans-Peter
Wiesner, Diana
Weishaupt, Jochen
Klose, Veronika
Wiesenfarth, Maximilian
Elmas, Zeynep
Herrmann, Christine
Parlak, Özlem
Günther, Kornelia
Saad, Rami
Weiland, Ulrike
Dupuis, Luc
Ludolph, Albert
Li, Liang
Kassubek, Jan
Dorst, Johannes
Roselli, Francesco
-
Funding
Funding for this research was provided by:
Target ALS
EU Joint Programme – Neurodegenerative Disease Research
Universität Ulm
- License Information
-
More Information
Article History
Received: 24 July 2025
Accepted: 23 February 2026
First Online: 3 March 2026
Declarations
:
: All serum samples used in this study were obtained from the University Hospital, Ulm, and authorised by Ulm University Ethical Committee (Approval no. 19/12). Written informed consent was obtained from all individual participants before the collection of serum samples. All experiments on mice have been approved by Tierforschungszentrum Ulm and by the Regierungspräsidium Tübingen under licence numbers 1440 and o.217–9.
: Not applicable.
: The authors declare no competing interests.
